Democratic president hopeful Bernie Sanders took aim at the pharmaceutical industry with a new bill that would provide the government with negotiating power, allow the import of lower-cost drugs from Canada, and requires reporting of information that affects drug pricing.
With the American public unhappy with the high cost of drugs, it was expected that prescription drugs would be an important issue for the 2016 presidential campaign. Democratic hopeful Senator Bernie Sanders (I-VT) is taking the first shot with a bill to battle rising prices.
Sanders and Representative Elijah Cummings (D-MD) rolled out their drug pricing bill, the Prescription Drug Affordability Act of 2015, which includes tactics like government power to directly negotiate drug prices and full disclosure of R&D and manufacturing costs, profits, and pricing in other countries.
“In the richest country in the history of the world, Americans should not have to live in fear that they will die because they cannot afford to take the life-saving medication they need,” Sanders said in a press conference.
The bill would allow US residents to import lower-cost medications from Canada, close the Medicare Part D donut hole for brand and generic drugs by 2017, restore the minimum rebate on drugs covered under Medicare Part D for low-income Medicare beneficiaries, prohibit anti-competitive arrangements between brand and generic drug makers, and require pharmaceutical companies to publicly report information that affects drug pricing.
The bill is cosponsored by Senator Al Franken (D-MN), and supported by the Alliance for Retired Americans, Social Security Works, the National Committee to Preserve Social Security and Medicare, National Center for Health Research, Public Citizen, Association of Clinicians for the Underserved, and RxRights.
Sanders acknowledged that passing the legislation will be difficult, and said he was unable to recall at time when the prescription drug industry lost a battle on Capitol Hill.
“But at a time when a huge majority of the American people want us to take action, when 74 percent of Republicans and 93 percent of Democrats, want the federal government to negotiate with the drug companies top lower prices, the time has come to say enough is enough,” he said.
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More